Abstract Interleukin 13 receptor alpha 2 (IL13Rα2) is increasingly recognized as a relevant
player in cancer invasion and metastasis. Despite being initially considered a decoy …

Simple Summary Cancer accounts for an increasing number of deaths year on year.
However, new immune-based therapies offer promise in the quest to address this unmet …

Cytokines play an essential role in the control of tumor cell development and multiplication.
However, the available literature provides ambiguous data on the involvement of these …

Purpose: Nanoparticles (NPs) of the polydopamine (PDA)-based, loaded with temozolomide
(TMZ) and conjugated with Pep-1 (Peptide-1) as a feasible nano-drug delivery system were …

Cancer remains the second leading cause of death worldwide despite modern
breakthroughs in medicine, and novel treatments are urgently needed. The revolutionary …

Background Previously, we discovered that human solid tumours, but not normal human
tissues, preferentially overexpress interleukin‐13Receptor alpha2, a high binding receptor …

Targeting cell surface receptors with immunotoxins provides a novel, unique and highly
potent treatment against cancers. A high expression of interleukin-13 (IL13) receptor α2 …

Introduction Tissue-based proteomic studies of colorectal cancer (CRC) metastasis have
delivered fragmented results, with very few therapeutic targets and prognostic biomarkers …

Adoptive chimeric antigen receptor (CAR) T cells designed to recognize specific tumor
antigens have shown promising results in cancer therapy. While CAR T cell therapy has …

Simple Summary Breast cancer is the most commonly diagnosed cancer and the second
leading cause of cancer deaths among women globally. Due to its biological heterogeneity …